Personalized Medicine: A New Normal for Therapeutic Success

被引:4
|
作者
Sarvan, M. S. [1 ]
Nori, Lakshmi Prasanthi [2 ]
机构
[1] Vignan Coll Pharm, Dept Pharm, Vadlamudi, India
[2] Vignans Fdn Sci Technol & Res Deemed Univ, Dept Pharmaceut Sci, Guntur 522213, Andhra Pradesh, India
关键词
Personalized medicine; precision medicine; genomics; biomarkers; epigenetics; DNA METHYLATION BIOMARKERS; DISEASES; PHARMACOGENOMICS; ASSOCIATION; EPIGENETICS; VALIDATION; METABOLISM; EXPRESSION;
D O I
10.36468/pharmaceutical-sciences.790
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this article is to provide a framework for understanding the principles of personalized and precision medicine. Since the advent of the human genome project in 1990, the approach to precision and accurate medicine has been changed. This turns the practice from the "one size fits all" paradigm into one that tailors patient identification, diagnosis and treatment. Personalized medicine has been a disputed vision of the future for two decades. A humanized approach to personalized medicine will offer the possibility of leveraging the physiology of processes and its application of personalized, predictive, participatory, precision and preventive P5 medicine. The predictive variables for the progression of a disease should be investigated within communities to determine preventive measures for at risk people and healthcare can be customized and participative. Accurate diagnosis, surveillance and treatment of diseases includes developments in the identification of biomarkers, the subsequent development of reliable signatures that suit complex disease states, as well as medical approaches that can be continually modified and modulated for dosage and medication selection. This review illustrates significant breakthroughs in the advancement of emerging technology and obstacles of personalized and precise medicine. It will create groundbreaking capabilities in the realization of fully individualized patient care.
引用
收藏
页码:416 / 429
页数:14
相关论文
共 50 条
  • [41] Inhaled antibiotics: the new era of personalized medicine?
    Biller, Julie A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (06) : 596 - 601
  • [42] Personalized medicine: new genomics, old lessons
    Kenneth Offit
    Human Genetics, 2011, 130 : 3 - 14
  • [43] ADAR Therapeutics as a New Tool for Personalized Medicine
    Bertoli, Matteo
    La Via, Luca
    Barbon, Alessandro
    GENES, 2025, 16 (01)
  • [44] The Microbiome Revolution: New Insights for Personalized Medicine
    Laterza, Lucrezia
    Mignini, Irene
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (09):
  • [45] Personalized medicine - a new reality in psoriatic arthritis?
    Al-Mossawi, Hussein
    Coates, Laura C.
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (08) : 449 - 451
  • [46] Personalized medicine in psychiatry: New technologies and approaches
    Costa e Silva, Jorge A.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (01): : S40 - S44
  • [47] PHARMACOGENOMICS OF HYPERTENSION: A NEW APPROACH FOR A PERSONALIZED MEDICINE
    Maggioni, C.
    Lanzani, C.
    Citterio, L.
    Catena, C.
    Bigazzi, R.
    Delli Carpini, S.
    Manunta, P.
    JOURNAL OF HYPERTENSION, 2019, 37 : E216 - E216
  • [48] Pharmacometabonomics in humans: a new tool for personalized medicine
    Everett, Jeremy R.
    PHARMACOGENOMICS, 2015, 16 (07) : 737 - 754
  • [49] SUCCESS OF FAMILY MEDICINE AS A NEW SPECIALTY
    ABRAMS, HK
    MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 1972, 16 (03): : 159 - &
  • [50] SUCCESS OF FAMILY MEDICINE AS A NEW SPECIALTY
    ABRAMS, HK
    JOURNAL OF MEDICAL EDUCATION, 1972, 47 (02): : 159 - &